127 related articles for article (PubMed ID: 38226968)
1. Effect of stoichiometry upon the characteristics of quercetin-arginine cocrystals formulated through solution crystallization.
Mishra M; Agrawal S; Bahadur P; Tiwari S
Drug Dev Ind Pharm; 2024 Feb; 50(2):163-172. PubMed ID: 38226968
[TBL] [Abstract][Full Text] [Related]
2. A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.
Hong C; Xie Y; Yao Y; Li G; Yuan X; Shen H
Pharm Res; 2015 Jan; 32(1):47-60. PubMed ID: 24939640
[TBL] [Abstract][Full Text] [Related]
3. Cocrystal of Apixaban-Quercetin: Improving Solubility and Bioavailability of Drug Combination of Two Poorly Soluble Drugs.
Zhang L; Kong D; Wang H; Jiao L; Zhao X; Song J; Yang D; Yang H; Yang S; Du G; Lu Y
Molecules; 2021 May; 26(9):. PubMed ID: 34063645
[TBL] [Abstract][Full Text] [Related]
4. Preparation of quercetin-nicotinamide cocrystals and their evaluation under
Wu N; Zhang Y; Ren J; Zeng A; Liu J
RSC Adv; 2020 Jun; 10(37):21852-21859. PubMed ID: 35516602
[TBL] [Abstract][Full Text] [Related]
5. Formation of Prenylated Chalcone Xanthohumol Cocrystals: Single Crystal X-Ray Diffraction, Vibrational Spectroscopic Study Coupled with Multivariate Analysis.
Budziak I; Arczewska M; Kamiński DM
Molecules; 2019 Nov; 24(23):. PubMed ID: 31766540
[TBL] [Abstract][Full Text] [Related]
6. Effects of Coformer and Polymer on Particle Surface Solution-Mediated Phase Transformation of Cocrystals in Aqueous Media.
Omori M; Watanabe T; Uekusa T; Oki J; Inoue D; Sugano K
Mol Pharm; 2020 Oct; 17(10):3825-3836. PubMed ID: 32870691
[TBL] [Abstract][Full Text] [Related]
7. Enhancing the Pharmaceutical Behavior of Nateglinide by Cocrystallization: Physicochemical Assessment of Cocrystal Formation and Informed Use of Differential Scanning Calorimetry for Its Quantitative Characterization.
Bruni G; Maggi L; Mustarelli P; Sakaj M; Friuli V; Ferrara C; Berbenni V; Girella A; Milanese C; Marini A
J Pharm Sci; 2019 Apr; 108(4):1529-1539. PubMed ID: 30476510
[TBL] [Abstract][Full Text] [Related]
8. Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid.
Li Z; Matzger AJ
Mol Pharm; 2016 Mar; 13(3):990-5. PubMed ID: 26837376
[TBL] [Abstract][Full Text] [Related]
9. Development of a pharmaceutical cocrystal with solution crystallization technology: Preparation, characterization, and evaluation of myricetin-proline cocrystals.
Liu M; Hong C; Yao Y; Shen H; Ji G; Li G; Xie Y
Eur J Pharm Biopharm; 2016 Oct; 107():151-9. PubMed ID: 27395394
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.
Tomaszewska I; Karki S; Shur J; Price R; Fotaki N
Int J Pharm; 2013 Sep; 453(2):380-8. PubMed ID: 23727143
[TBL] [Abstract][Full Text] [Related]
11. Melt Crystallization of Celecoxib-Carbamazepine Cocrystals with the Synchronized Release of Drugs.
Chen A; Cai P; Luo M; Guo M; Cai T
Pharm Res; 2023 Feb; 40(2):567-577. PubMed ID: 36348133
[TBL] [Abstract][Full Text] [Related]
12. Novel Aceclofenac Cocrystals with l-Cystine: Virtual Coformer Screening, Mechanochemical Synthesis, and Physicochemical Investigations.
Kumar S; Gupta A; Prasad R; Singh S
Curr Drug Deliv; 2021; 18(1):88-100. PubMed ID: 32807053
[TBL] [Abstract][Full Text] [Related]
13. Cocrystals of quercetin with improved solubility and oral bioavailability.
Smith AJ; Kavuru P; Wojtas L; Zaworotko MJ; Shytle RD
Mol Pharm; 2011 Oct; 8(5):1867-76. PubMed ID: 21846121
[TBL] [Abstract][Full Text] [Related]
14. Chrysin cocrystals: Characterization and evaluation.
Chadha R; Bhalla Y; Nandan A; Chadha K; Karan M
J Pharm Biomed Anal; 2017 Feb; 134():361-371. PubMed ID: 27894779
[TBL] [Abstract][Full Text] [Related]
15. Formation of itraconazole-succinic acid cocrystals by gas antisolvent cocrystallization.
Ober CA; Gupta RB
AAPS PharmSciTech; 2012 Dec; 13(4):1396-406. PubMed ID: 23054991
[TBL] [Abstract][Full Text] [Related]
16. Is Failure of Cocrystallization Actually a Failure? Eutectic Formation in Cocrystal Screening of Hesperetin.
Chadha K; Karan M; Chadha R; Bhalla Y; Vasisht K
J Pharm Sci; 2017 Aug; 106(8):2026-2036. PubMed ID: 28456725
[TBL] [Abstract][Full Text] [Related]
17. Novel cocrystals of itraconazole: Insights from phase diagrams, formation thermodynamics and solubility.
Vasilev NA; Surov AO; Voronin AP; Drozd KV; Perlovich GL
Int J Pharm; 2021 Apr; 599():120441. PubMed ID: 33675927
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism and stability of ibuprofen/nicotinamide cocrystal: The effect of the crystalline synthesis method.
Guerain M; Guinet Y; Correia NT; Paccou L; Danède F; Hédoux A
Int J Pharm; 2020 Jun; 584():119454. PubMed ID: 32464230
[TBL] [Abstract][Full Text] [Related]
19. Fast dissolving eutectic compositions of curcumin.
Goud NR; Suresh K; Sanphui P; Nangia A
Int J Pharm; 2012 Dec; 439(1-2):63-72. PubMed ID: 23041131
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of electrospray deposition for rapid screening of the cocrystal formation and single step, continuous production of pharmaceutical nanococrystals.
Emami S; Siahi-Shadbad M; Barzegar-Jalali M; Adibkia K
Drug Dev Ind Pharm; 2018 Jun; 44(6):1034-1047. PubMed ID: 29347850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
